DV
Dividend Vision

VIVS Stock — VivoSim Labs, Inc.

VivoSim Labs, Inc. (VIVS)

Updated October 16, 2026.

VIVS is a Stock. Total return is -100.0% over the past 14.7 years, 728.5 points behind SPY at 628.5%.

VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company that provides drug testing using three-dimensional human tissue models of liver and intestine, helping pharmaceutical and biotech partners assess toxicology and predict side effects of drug candidates during development. The company does not currently distribute dividends. VivoSim Labs appeals primarily to growth-oriented investors interested in biotechnology innovations rather than income investors.

VIVS dividend yield and income

Price as of 2026-10-16.

The payment date is 08/19/2020.

VIVS performance versus SPY

Price and return data through 2026-10-16.

Total return is -100.0% over the past 14.7 years, 728.5 points behind SPY at 628.5%. Over the past year its total return — price change plus distributions reinvested — is -94.0%. Its deepest 1-year drawdown was 94.7%.

WindowTotal returnCAGR
1M-39.6%—
3M-74.3%—
6M-89.5%—
YTD-91.3%—
1Y-94.0%—
2Y CAGR—-83.20%
3Y CAGR—-78.10%
5Y CAGR—-71.10%
10Y CAGR—-57.90%
Since inception (14.7 years)-100.0%-41.40%

VIVS key facts

Asset type
Stock
Asset class
Equity
Inception date
02/14/2012
Distribution frequency
None
Last close
$0.16 (as of 2026-10-16)
Market cap
$2,602,421
Average volume
818269.0
Payment date
08/19/2020
Beta
1.49
Payout ratio
0.0%
EPS
$-4.22

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

VIVS risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 94.7%.

Who may consider VIVS — and who may not

It is a weaker fit for investors who need monthly cash flow (VIVS does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on VIVS

Tagged: Healthcare.

Frequently asked questions

Does VIVS pay monthly?

No. VIVS does not currently distribute.

When does VIVS pay a dividend?

VIVS does not currently distribute. The payment date is 08/19/2020.

How has VIVS performed?

Total return is -100.0% over the past 14.7 years, 728.5 points behind SPY at 628.5%. Over the past year its total return — price change plus distributions reinvested — is -94.0%. Its deepest 1-year drawdown was 94.7%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.